NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy Growth Corporation (NYSE:CGC), MSG Networks Inc. (NYSE:MSGN), ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Mistras Group Inc (NYSE:MG), Rowan Companies PLC (NYSE:RDC), and Chemours Company (NYSE:CC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CGC DOWNLOAD: http://Fundamental-Markets.com/register/?so=CGC
MSGN DOWNLOAD: http://Fundamental-Markets.com/register/?so=MSGN
ANIP DOWNLOAD: http://Fundamental-Markets.com/register/?so=ANIP
MG DOWNLOAD: http://Fundamental-Markets.com/register/?so=MG
RDC DOWNLOAD: http://Fundamental-Markets.com/register/?so=RDC
CC DOWNLOAD: http://Fundamental-Markets.com/register/?so=CC
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Canopy Growth Corporation (NYSE:CGC), MSG Networks Inc. (NYSE:MSGN), ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Mistras Group Inc (NYSE:MG), Rowan Companies PLC (NYSE:RDC), and Chemours Company (NYSE:CC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CANOPY GROWTH CORPORATION (CGC) REPORT OVERVIEW
Canopy Growth's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Canopy Growth reported revenue of $64.48MM vs $27.92MM (up 130.95%) and analysts estimated basic earnings per share -$0.31 vs -$0.02. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Canopy Growth reported revenue of $139.07MM vs $76.15MM (up 82.64%) and analysts estimated basic earnings per share -$0.31 vs -$0.11. Analysts expect earnings to be released on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.01. The estimated EPS forecast for the next fiscal year is $0.34 and is expected to report on June 26th, 2019.
To read the full Canopy Growth Corporation (CGC) report, download it here: http://Fundamental-Markets.com/register/?so=CGC
-----------------------------------------
MSG NETWORKS INC. (MSGN) REPORT OVERVIEW
MSG Networks' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, MSG Networks reported revenue of $164.46MM vs $157.46MM (up 4.45%) and analysts estimated basic earnings per share $0.63 vs $0.55 (up 14.55%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, MSG Networks reported revenue of $696.65MM vs $675.35MM (up 3.15%) and analysts estimated basic earnings per share $3.83 vs $2.22 (up 72.52%). Analysts expect earnings to be released on February 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.65. The estimated EPS forecast for the next fiscal year is $2.72 and is expected to report on August 21st, 2019.
To read the full MSG Networks Inc. (MSGN) report, download it here: http://Fundamental-Markets.com/register/?so=MSGN
-----------------------------------------
ANI PHARMACEUTICALS, INC. (ANIP) REPORT OVERVIEW
ANI Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, ANI Pharmaceuticals reported revenue of $50.70MM vs $48.16MM (up 5.27%) and analysts estimated basic earnings per share $0.43 vs $0.41 (up 4.88%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ANI Pharmaceuticals reported revenue of $176.84MM vs $128.62MM (up 37.49%) and analysts estimated basic earnings per share -$0.09 vs $0.34. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.00. The estimated EPS forecast for the next fiscal year is $5.67 and is expected to report on February 26th, 2019.
To read the full ANI Pharmaceuticals, Inc. (ANIP) report, download it here: http://Fundamental-Markets.com/register/?so=ANIP
-----------------------------------------
MISTRAS GROUP INC (MG) REPORT OVERVIEW
Mistras Group's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Mistras Group reported revenue of $182.17MM vs $179.57MM (up 1.45%) and basic earnings per share -$0.04 vs -$0.25. Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $0.93 and is expected to report on March 11th, 2019.
To read the full Mistras Group Inc (MG) report, download it here: http://Fundamental-Markets.com/register/?so=MG
-----------------------------------------
ROWAN COMPANIES PLC (RDC) REPORT OVERVIEW
Rowan Companies' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Rowan Companies reported revenue of $192.90MM vs $291.60MM (down 33.85%) and analysts estimated basic earnings per share -$1.13 vs -$0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Rowan Companies reported revenue of $1,282.80MM vs $1,843.20MM (down 30.40%) and analysts estimated basic earnings per share $0.58 vs $2.56 (down 77.34%). Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$3.29 and is expected to report on February 27th, 2019.
To read the full Rowan Companies PLC (RDC) report, download it here: http://Fundamental-Markets.com/register/?so=RDC
-----------------------------------------
CHEMOURS COMPANY (CC) REPORT OVERVIEW
Chemours' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Chemours reported revenue of $1,628.00MM vs $1,584.00MM (up 2.78%) and analysts estimated basic earnings per share $1.56 vs $1.12 (up 39.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Chemours reported revenue of $6,183.00MM vs $5,400.00MM (up 14.50%) and analysts estimated basic earnings per share $4.04 vs $0.04 (up 10,000.00%). Analysts expect earnings to be released on February 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.19. The estimated EPS forecast for the next fiscal year is $5.57 and is expected to report on February 13th, 2019.
To read the full Chemours Company (CC) report, download it here: http://Fundamental-Markets.com/register/?so=CC
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.